Hepatology, cancer, Immunology, and Neurology are just a few domains of research which have included research peptide Thymosin alpha-1 within the scope of their studies. Its relevance across a wide ...

Thymosin Alpha-1 (Tα1) is an endogenously occurring peptide originally isolated from thymic tissue, composed of 28 amino acids. It has emerged as a molecule of interest across various research domains ...

The thymosin alpha 1 (Tα1) peptide is a naturally occurring peptide largely formed from the thymus gland. It has been hypothesized to play a significant role in the control of immunological responses.

The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of thymosin alpha-1 (TA1) are reviewed. Clinical trials of TA1 for chronic hepatitis B or C have ...

Just as the coronavirus pandemic began its rapid and deadly spread across the United States, a well-known doctor named Dominique Fradin-Read told thousands of viewers tuning into an Instagram Live ...

Gufic Biosciences Limited (Gufic) have received DCGI approval for Thymosin Alpha-1 (Immunocin α – A Brand of Gufic for the said drug) as an add-on therapy for the treatment of moderate-to-severe COVID ...